Mamta Jain
Director, Clinical Research · University of Texas Southwestern Medical Center
Credentials: · · · ·
History
PresentClinical Research · University of Texas Southwestern Medical Center
- 1992–1996
Research
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
New England Journal of Medicine · 2021 · 1,404 citations
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
New England Journal of Medicine · 2021 · 351 citations
Journal of Hepatology · 2007 · 209 citations
- ML
13 papers
12 papers
- MS
11 papers
11 papers
10 papers
10 papers
- MG
10 papers
10 papers
Grants
- 2005–2010
Molecular Basis of Interferon Response in HCV
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $621K · Ut Southwestern Medical Center
- 2000–2008
u.t. Southwestern Adult Aids Clinical Trials Unit
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $5.4M · Ut Southwestern Medical Center
- 2004–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $314.5K · Ut Southwestern Medical Center
Clinical trials
- 2026–2027
HIV/HBV/HCV Triple Screening in Primary Care
Principal investigator · Not yet recruiting
University of Texas Southwestern Medical Center
- 2020–2021
Atovaquone for Treatment of COVID-19
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2016–2017
Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study
Principal investigator · Terminated · Phase 4
University of Texas Southwestern Medical Center
- 2005–2013
Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Principal investigator · Completed
University of Texas Southwestern Medical Center